New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 25, 2014
04:55 EDTSNE, SNE, SNE, SNE, SNE, SCMP, SCMP, SCMP, SCMP, SCMP, PRGO, PRGO, PRGO, PRGO, PRGO, OMER, OMER, OMER, OMER, OMER, NBY, NBY, NBY, NBY, NBY, LMNS, LMNS, LMNS, LMNS, LMNS, HALO, HALO, HALO, HALO, HALO, CAJ, CAJ, CAJ, CAJ, CAJ, AKRX, AKRX, AKRX, AKRX, AKRX, AGN, AGN, AGN, AGN, AGN, ACL, ACL, ACL, ACL, ACL, ABT, ABT, ABT, ABT, ABTAmerican Society of Cataract and Refractive Surgery to hold a symposium
2014 ASCRS-SOA Symposium & Congress is being held in Boston, MA on April 25-29.
News For ABT;ACL;AGN;AKRX;CAJ;HALO;LMNS;NBY;OMER;PRGO;SCMP;SNE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
January 27, 2015
13:19 EDTSNESony to cut additional 1,000 employees in smartphone business, Nikkei says
Subscribe for More Information
January 26, 2015
17:34 EDTAGNActavis registration statement for Allergan acquisition declared effective
Subscribe for More Information
07:05 EDTNBYNovaBay signs Avenova distribution agreement with Cardinal Health
Subscribe for More Information
07:05 EDTAKRXAkorn price target raised to $55 from $45 at Piper Jaffray
Piper Jaffray raised its price target for Akorn shares to $55 saying approvals of "seemingly minor" abbreviated New Drug Application opportunities, like last week's Phenylephrine Hydrochloride Ophthalmic Solution, could in the aggregate drive significant upside to consensus estimates in 2015 and beyond. Piper reiterates an Overweight rating on shares of Akorn.
January 23, 2015
10:07 EDTSNEHigh option volume stocks
High option volume stocks: CE TSM RYAM NOC SNE FXCM LBTYA TKMR LF STT
06:17 EDTSNESony to delay earnings report due to last year's cyberattack
Subscribe for More Information
January 22, 2015
06:54 EDTSNESony sees mobile success in Middle East and Africa, WSJ says
Subscribe for More Information
January 21, 2015
12:30 EDTAGNGlaxoSmithKline 'admired' by Pfizer CEO, FT reports
Subscribe for More Information
08:23 EDTNBYNovaBay to hold a conference call
Subscribe for More Information
07:22 EDTAGNActavis price target raised to $330 from $280 at Deutsche Bank
Subscribe for More Information
06:36 EDTSNESony's 'The Interview' nets $40M in online and TV sales, Re/code says
Subscribe for More Information
06:35 EDTSNESony planning to reduce headcount in Japan by 1,500, Variety reports
According to media reports in Japan, Variety reports that Sony is planning to reduce its headcount in various divisions in Japan by about 1,500 by the end of FY14 through early retirement programs. The process, which began last August, involved Sony's corporate planning and finance departments, but has now been expanded to include corporate headquarters staff. Reference Link
January 20, 2015
18:38 EDTSNESony probed Indian operations for corruption, Bloomberg reports
Subscribe for More Information
11:16 EDTPRGOPerrigo management to meet with B. Riley
Subscribe for More Information
10:55 EDTSCMPSucampo founders' share registration removes overhang, says Cantor
Subscribe for More Information
08:44 EDTSCMPSucampo share sales to remove big overhang, says Roth Capital
Subscribe for More Information
08:09 EDTAKRXAkorn price target raised to $49 from $44 at Jefferies
Jefferies raised its price target for Akorn shares to $49 to reflect its FY15 estimates. The firm keeps a Buy rating on the stock.
07:11 EDTAKRXAkorn receives FDA approval for Phenylephrine Hydrochloride Ophthalmic Solution
Subscribe for More Information
07:06 EDTNBYNovaBay expanding sales force for Avenova
NovaBay Pharmaceuticals announced that it is expanding its sales force for its innovative eye care product Avenova from 15 sales representatives to 35 representatives. Ron Najafi, Ph.D., Chairman and CEO of NovaBay, commented, “We plan to further increase our sales force to more than 50 representatives by July, which will allow us to reach more of the estimated 30 million Americans who suffer from eyelid conditions. We estimate the market opportunity for Avenova at $500 million annually in the U.S. alone.”
06:22 EDTCAJCanon upgraded to Hold from Sell at Deutsche Bank
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use